Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16009950 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer
Condition: Carcinoma, Squamous Cell
Interventions: Procedure: FDG-PET/CT;   Drug: Cetuximab

Indicates status has not been verified in more than two years